Immunofluorescence staining
EWS cells were seeded on fibronectin-coated coverslips (Sigma) and stimulated after 24h with anti-CD99 0662mAb (3μg/ml). After washing in PBS, cells were fixed in 4% paraformaldehyde and permeabilized in Triton X-100 0.15%-PBS, blocked in 4% BSA and incubated with the following specific antibodies: anti-CD99 primary antibody (Abcam, clone 12E7); anti-RAS (Santa Cruz Biotechnologies, FL-189) anti-LAMP-1 PE (BD Pharmigen); anti-RAB11 (Abcam); anti-clathrin polyclonal antibody (Cell Signaling); anticaveolin-1 (BD-transduction labs); anti-IGF-1R (Santa Cruz Biotechnologies, clone C20); anti-IGF-1R PE (Pharmigen); anti-RAB5 (Thermo Scientific); anti-Rac1 (Santa Cruz Biotechnologies, clone C14). Nuclei were counterstained with Hoechst 33258.
Immunoistochemistry staining
Sections (5 μm) from formalin-fixed, paraffinembedded tumor xenografts were placed on poly-L-lysine coated slides (Sigma). Avidin-biotin-peroxidase procedure was used for immunostaining. Briefly, sections were treated sequentially with xylene and ethanol to remove paraffin. For immunohistochemical detection of IGF-IR, sections were pretreated with a citrate buffer solution [0.01 mol/L citric acid and 0.01 mol/L sodium citrate (pH 6.0)] in a microwave oven at 750 W for three cycles of 5 min each. Endogenous peroxidase activity was blocked by treatment with 3% hydrogen peroxide in methanol for 30 min at room temperature. A blocking step with normal goat serum (Vector, Burlinga me, CA) was used. This treatment ensured antigen retrieval from samples. The following primary antibodies (anti-IGF-1R β-subunit, clone C-20, diluted 1:50; anti-RAS, clone FL-189, diluted 1: 100 and anti-Rac1, clone C14, diluted 1: 100, Santa Cruz Biotechnologies) were applied overnight in a moist chamber at 4°C. The following day, tissue sections were incubated with a secondary biotinylated anti-rabbit antibody and with an avidin-biotin-peroxidase complex (Vector).
The final reaction product was revealed by exposure to 0.03% diaminobenzidine (Sigma), and nuclei were counterstained with Mayer's hematoxylin.
Acridine orange (AO) immunofluorescence
6647 and LAP-35 cells were seeded on fibronectin coated-dishes and after 48h stimulated with anti-CD99 0662mAb (3μg/ml) for 3h. After treatment, cells were washed with PBS and then stained with 1 μg/ml AO in PBS for 15 min at 37°C and nuclei were counterstained with vital Hoechst 33342 (Sigma). Apoptosis was induced in 6647 or LAP-35 dominant negative RAS cells (hRAS N17) by treating them with 3μg/ml 0662mAb for 3h at 37°C. Control or treated cells were stained with AO 15 min at 37°C and nuclei were counterstained with vital Hoechst 33342 (Sigma).
Western blotting and immunoprecipitation
Cells were lysed with phospho-protein extraction Buffer (Upstate) supplemented with proteasephosphatase cocktail inhibitor (Sigma). Proteins of interest were detected with specific antibodies: anti-GAPDH (Santa Cruz Biotechnology, FL-335), antipan RAS (Thermo Scientific, Ras10), anti-ATG7 (Cell signaling Technologies, 2631), anti-IGF-1R (Santa Cruz Biotechnology, C-20), anti-CD99 (Santa Cruz Biotechnology, 12E7), anti-LC3 (Cell Signaling, D11), phospho-ERK/Thr202-Tyr204 (Covance), anti Rac1 (Santa Cruz Biotechnology, C-14), anti-MDM2 (Calbiochem, 2A10). For immunoprecipitation, 900 μg of cell lysates were incubated for 16h with Protein A/G-Plus-agarose beads (Calbiochem) in the presence of 2 μg of anti-IGF-1R antibody (Calbiochem, αIR-3).
Immunoprecipitates and 40 μg total lysates were then resolved on a 10% Tris-HCl gel and immunoblotted with specific antibodies.
CD99 internalization
ELISA assay was performed on 70,000 cells/timepoint seeded in multi 24 plates and starved for 3h, then mAb; subsequently cells were washed in TBS 1X, fixed in 3.7% TBS-paraformaldehyde and blocked in 1% TBS-BSA. After the incubation with the anti-mouse secondary antibody, the relative substrate (BIO-RAD Cat# 172-1063) was added to the cells. The reaction was stopped by adding NaOH 0.4 N, then absorbance was read at 405 nm.
CD99 exposure was evaluated by indirect immunofluorescence: after 0662mAb exposure, a pellet of 500 000 cells has incubated with goat anti-mouse IgG (H+L) FITC (Thermo Fisher Scientific Inc) for 30 min, the reaction was stopped by adding serum-free medium. Cells resuspended in 1μg/ml ethidium bromide-PBS were processed for FACS analysis.
Treatment with inhibitor or siRNA of Rac1
The Rac1 inhibitor, EHT 1864 (Tocris), was added at 25 μM in culture medium 24h after cell seeding and renewed every day. After 48h control or treated cells were exposed to 0662mAb and subsequently analyzed. Transient Rac1 depletion was achieved by siRNA approaches using anti-Rac1 oligos commercially available. Scrambled (ONTARGETplus siCONTROL, Thermo Scientific) was used as control. All were administered at 100 picomoles. Cells were seeded in 60-mm plates in standard medium (3 × 10 5 cells per plate) and transfected after 24h (Lipofectamine 2000, Life Technologies). 48h later, cells were treated with 3 μg/ml of 0662mAb for 2h and harvested for vital count.
Network analyses of gene expression array
Biological pathways were defined according to "GeneGO Pathway Maps" manually curated database, instead ontologies according to Gene Ontology database. Enrichment was tested for significance by modified Fisher's Exact Test corrected by FDR and considered significant if p-value ≤ 0.1. Network analysis of biologically related terms was performed with the direct interaction method in GeneGO, were an edge connecting two genes indicates their direct biological relation according to GeneGO database.
In vivo treatments with anti-CD99 antibody
Female athymic 4-5-week-old Crl:CD-1nu/nuBR mice (Charles River Italia, Italy) were subcutaneously injected with 5 × 10 6 EWS cells. The animals were randomised into two groups. In the group treated with anti-CD99 antibody alone, each mouse received s. 
